Below are the top 10 Biotechnology stocks with highest Return on Assets ratio (ROA) for the last 12 months. ROA shows a company's efficiency in making profits from its assets. It is equal to net profits divided by total assets.
InterMune, Inc. (NASDAQ:ITMN) has the 1st highest Return on Assets in this segment of the market. Its ROA was 58.29% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.24 for the same period. CARDIOME PHARMA CORP (NASDAQ:CRME) has the 2nd highest Return on Assets in this segment of the market. Its ROA was 52.29% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.97 for the same period. Maxygen, Inc. (NASDAQ:MAXY) has the 3rd highest Return on Assets in this segment of the market. Its ROA was 42.21% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.23 for the same period. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has the 4th highest Return on Assets in this segment of the market. Its ROA was 34.38% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.96 for the same period.Gilead Sciences, Inc. (NASDAQ:GILD) has the 5th highest Return on Assets in this segment of the market. Its ROA was 27.15% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.75 for the same period.
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) has the 6th highest Return on Assets in this segment of the market. Its ROA was 26.96% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.43 for the same period. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) has the 7th highest Return on Assets in this segment of the market. Its ROA was 26.29% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 1.06 for the same period. GTx, Inc. (NASDAQ:GTXI) has the 8th highest Return on Assets in this segment of the market. Its ROA was 25.08% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.99 for the same period. Transition Therapeutics Inc. (NASDAQ:TTHI) has the 9th highest Return on Assets in this segment of the market. Its ROA was 22.15% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.59 for the same period. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has the 10th highest Return on Assets in this segment of the market. Its ROA was 21.55% for the last 12 months. Its Asset Turnover ratio (revenue divided by assets) was 0.67 for the same period.
No comments:
Post a Comment